Ceptaris Receives FDA Approval for VALCHLOR™ (mechlorethamine) Gel for the Treatment of 

Ceptaris Receives FDA Approval for VALCHLOR™ (mechlorethamine) Gel for the Treatment of Stage IA and IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma in Patients Who Have Received Prior Skin-Directed Therapy
Business Wire
 
View Comments